Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness

By Thanusha Pillay

June 14, 2024

Introduction

Inadequate care during infancy can have lasting repercussions, impacting various sectors and necessitating increased expenditure on health, social, educational, and judicial services. Positive parenting is a growing public health priority and parenting programmes have been shown to be valuable and effective. Universal Early Parenting Programmes are increasingly popular for enhancing positive parenting practices and addressing skill and attitude gaps across diverse populations.

The Efficacy of Universal Parenting Interventions

Research underscores the potential of early parenting programmes in enhancing parental knowledge and skills. While short-term benefits are evident, long-term impacts of universal interventions on parenting and child development are not thoroughly investigated.

Exploring the Parent and Infant Programme

This study looked into the cost and cost-effectiveness of the Parent and Infant (PIN) programme, a universal intervention targeting parental attitudes and responsive parenting strategies during the early years. The researchers piloted the program in two sites in the Republic of Ireland and compared it to services as usual (SAU). They assessed the cost-effectiveness of the program from an Irish health and social care perspective over 24 months. The primary outcome measure was the Parenting Sense of Competence Scale (PSOC), and by focusing on parent satisfaction this analysis sheds light on the programme’s efficacy.

Fig. 1

Figure 1. Overview of the PIN programme adapted from Hickey et al., 2020

Results and Cost Analysis

With 163 parent-infant dyads analysed (86 in the programme, 77 control), the PIN programme demonstrated a mean cost of €647 per dyad. The PIN service achieved a mean incremental cost-effectiveness of €614 per PSOC unit gained. At a willingness-to-pay of €1,000 per one unit change in the PSOC, the PIN programme proved cost-effective compared to SAU. The PIN programme showcased positive impacts on parental competence and was viable at a reasonable threshold.

Discussion and Implications

While the study highlights the success of the PIN programme, challenges in evaluating the cost-effectiveness of early interventions persist. The complexities of assessing outcomes in children, coupled with the need for a broader evaluative framework, highlight the necessity for further research and nuanced approaches to appraise the effectiveness of such programmes.

Conclusion

The study emphasise the potential of Universal Early Parenting Programmes in enhancing parental competence and fostering positive childhood behavioural outcomes. Navigating cost-effectiveness challenges, the field requires more research and robust trials to inform policy decisions and resource allocation effectively.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.